Congress Asset Management CO Vertex Pharmaceuticals Inc Transaction History

Congress Asset Management CO

$13.6 Billion
Q1 2024

A detailed history of Congress Asset Management CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Congress Asset Management CO holds 1,375 shares of VRTX stock, worth $662,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,375

Previous 1,375 -0.0%

Holding current value

$662,598

Previous $559,000 2.68%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 04, 2024	SELL	$343.0 - $410.68 $6,517 - $7,802	-19 Reduced 1.36%	1,375 $559,000
Q3 2023 Nov 01, 2023	SELL	$338.18 - $362.46 $42,272 - $45,307	-125 Reduced 8.23%	1,394 $484,000
Q1 2023 Apr 21, 2023	SELL	$283.23 - $323.1 $17,560 - $20,032	-62 Reduced 3.92%	1,519 $478,000
Q4 2022 Jan 18, 2023	SELL	$285.76 - $321.48 $5,715 - $6,429	-20 Reduced 1.25%	1,581 $0
Q3 2022 Nov 08, 2022	SELL	$273.83 - $305.53 $4.81 Million - $5.37 Million	-17,578 Reduced 91.65%	1,601 $464,000

Q2 2022 Aug 02, 2022	BUY	$234.96 - $292.55 $4 Million - $4.98 Million	17,028 Added 791.63%	19,179 $5.4 Million
Q1 2022 Apr 20, 2022	SELL	$221.42 - $260.97 $288,288 - $339,782	-1,302 Reduced 37.71%	2,151 $561,000
Q4 2021 Jan 28, 2022	SELL	$177.01 - $223.45 $117,888 - $148,817	-666 Reduced 16.17%	3,453 $758,000
Q3 2021 Nov 08, 2021	SELL	$181.39 - $202.99 $61.2 Million - $68.5 Million	-337,617 Reduced 98.79%	4,119 $747,000
Q2 2021 Aug 05, 2021	SELL	$187.49 - $221.1 $115,306 - $135,976	-615 Reduced 0.18%	341,736 $68.9 Million
Q1 2021 May 05, 2021	BUY	$207.02 - $241.31 $6.19 Million - $7.22 Million	29,923 Added 9.58%	342,351 $73.6 Million
Q4 2020 Jan 26, 2021	BUY	$207.01 - $276.09 $2.26 Million - $3.02 Million	10,938 Added 3.63%	312,428 $73.8 Million
Q3 2020 Nov 03, 2020	BUY	$255.65 - $303.1 $727,068 - $862,016	2,844 Added 0.95%	301,490 $82 Million
Q2 2020 Jul 23, 2020	SELL	$225.48 - $295.8 $1.15 Million - $1.51 Million	-5,099 Reduced 1.68%	298,646 $86.7 Million
Q1 2020 Apr 21, 2020	SELL	$199.77 - $247.81 $733,555 - $909,958	-3,672 Reduced 1.19%	303,745 $72.3 Million
Q4 2019 Feb 10, 2020	SELL	$166.71 - $223.91 $239,895 - $322,206	-1,439 Reduced 0.47%	307,417 $67.3 Million
Q3 2019 Nov 01, 2019	BUY	$166.23 - $187.09 $960,643 - $1.08 Million	5,779 Added 1.91%	308,856 $52.3 Million
Q2 2019 Aug 07, 2019	BUY	$164.61 - $190.37 $3.66 Million - $4.23 Million	22,210 Added 7.91%	303,077 $55.6 Million
Q1 2019 May 08, 2019	BUY	$163.73 - $194.7 $379,689 - $451,509	2,319 Added 0.83%	280,867 $51.7 Million
Q4 2018 Jan 25, 2019	BUY	$151.91 - $192.21 $2.61 Million - $3.3 Million	17,172 Added 6.57%	278,548 $46.2 Million
Q3 2018 Oct 26, 2018	BUY	$167.73 - $192.74 $1.45 Million - $1.67 Million	8,644 Added 3.42%	261,376 $50.4 Million
Q2 2018 Jul 25, 2018	BUY	$145.72 - $169.96 $36.8 Million - $43 Million	252,732 New	252,732 $43 Million

Others Institutions Holding VRTX

# of Institutions

1,625

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account

Congress Asset Management CO Vertex Pharmaceuticals Inc Transaction History